France In-Vitro Diagnostics (IVD) Market, Impact of COVID-19, Industry Trends, Growth, Opportunity Company Overview, Sales Analysis, Forecast
In-vitro diagnostics (IVDs) are a vital part of today’s healthcare system. It is used to diagnose, screen, scan, and assess predispositions to diseases monitoring. They are thereby contributing to the available medical information regarding a patient. Further allowing earlier and more targeted treatments, IVDs help reduce hospital stays; reduce costs and economic growth in the long run. As per the Renub Research report, the France In-Vitro Diagnostics market is expected to reach US$ 2.1 Billion by the end of the year 2026.
The Market for In-Vitro Diagnostic is a dynamic sector in the French medical market. Currently, the industry is undergoing significant changes. However, as the country struggles with the ever-increasing financial burdens of an ageing population and a comprehensive national health care system, the requirements of leveraging the cost/benefit advantages of effective diagnostics are becoming more and more visible in the industry.
Another important IVD market in France is that the country’s private medical analysis laboratories merge into larger units. Usually, several private laboratories join together as a Soci?t?sd’ Exercise Liberal (liberal exercise company) known in France as an SEL. Within an SEL, each laboratory specializes in a specific type of analysis. Besides, the consolidating and regrouping of laboratories also lead to a rapidly shrinking number of biologists and laboratories, especially private laboratories, in the past few years. However, these changes are complex at first but could make the market more efficient in the long run. The France IVD Market Size was valued at US$ 1.9 Billion in 2020.
The diagnostic tests in the country are assigned as a reimbursement percentage depending on the type of test, so the biologists in a public or a private laboratory can choose whatever brands of reagent they wish to use for a given diagnostic. However, regardless of their choices, they have reimbursed the percentage of cost predetermined for that kind of test. In general, the rates of reimbursement for France’s public health insurance are as follows:
France being a developed region with a well-structured healthcare system has many players in the in-vitro diagnostics market. Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific and Sysmex Corporation are prime companies in the France In-Vitro Diagnostics (IVD) Market.
COVID-19 Impact on IVD Market of France:
In the France IVD market, Infectious disease tests, particularly for respiratory and hospital-acquired infections, are anticipated to have strong growth.
Medical tests deemed non-essential, say routine health checks, bone health, hormone, will suffer the most due to postponement. More on this essential IVD tests for life-threatening conditions like cardiac, transplant, cancer, obstetrics, blood screening will be less affected.
A general drop of inpatient visits to hospitals and clinics has occurred as a result of lockdown measures.
Large investments in new diagnostic instruments not related to infectious disease testing will slow down as hospitals and labs prepare for the predicted economic downturn.
Renub Research report titled “France In-Vitro Diagnostics (IVD) Market By Segments (Immunochemistry, Hematology, Infectious Immunology, Microbiology, Bio-chemistry, Genetic Testing), Types (Laboratory Reagents, Instruments), Companies (Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Sysmex Corporation)” provides a complete analysis of France In-Vitro Diagnostics (IVD) Industry.
Types - France In-Vitro Diagnostics (IVD) Market have been covered from 2 viewpoints:
1. Laboratory Reagents
2. Instruments
Segments - France In-Vitro Diagnostics (IVD) Market have been covered from 6 viewpoints:
1. Immunochemistry
2. Hematology
3. Infectious Immunology
4. Microbiology
5. Bio-chemistry
6. Genetic Testing
Reimbursement Policy
1. Public
2. Private & Insurance
Companies have been covered from 3 viewpoints
1. Roche Diagnostics
2. Abbott Diagnostics
3. Siemens Healthineers
4. Danaher Corporation
5. Thermo Fisher Scientific
6. Sysmex Corporation
The Market for In-Vitro Diagnostic is a dynamic sector in the French medical market. Currently, the industry is undergoing significant changes. However, as the country struggles with the ever-increasing financial burdens of an ageing population and a comprehensive national health care system, the requirements of leveraging the cost/benefit advantages of effective diagnostics are becoming more and more visible in the industry.
Another important IVD market in France is that the country’s private medical analysis laboratories merge into larger units. Usually, several private laboratories join together as a Soci?t?sd’ Exercise Liberal (liberal exercise company) known in France as an SEL. Within an SEL, each laboratory specializes in a specific type of analysis. Besides, the consolidating and regrouping of laboratories also lead to a rapidly shrinking number of biologists and laboratories, especially private laboratories, in the past few years. However, these changes are complex at first but could make the market more efficient in the long run. The France IVD Market Size was valued at US$ 1.9 Billion in 2020.
The diagnostic tests in the country are assigned as a reimbursement percentage depending on the type of test, so the biologists in a public or a private laboratory can choose whatever brands of reagent they wish to use for a given diagnostic. However, regardless of their choices, they have reimbursed the percentage of cost predetermined for that kind of test. In general, the rates of reimbursement for France’s public health insurance are as follows:
- Screenings for HIV or Hepatitis C are entirely free for all patients.
- Other laboratory analyses reimbursed at 60-70 percent for most patients (private insurance will generally reimburse the remaining 30-40 percent)
France being a developed region with a well-structured healthcare system has many players in the in-vitro diagnostics market. Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific and Sysmex Corporation are prime companies in the France In-Vitro Diagnostics (IVD) Market.
COVID-19 Impact on IVD Market of France:
In the France IVD market, Infectious disease tests, particularly for respiratory and hospital-acquired infections, are anticipated to have strong growth.
Medical tests deemed non-essential, say routine health checks, bone health, hormone, will suffer the most due to postponement. More on this essential IVD tests for life-threatening conditions like cardiac, transplant, cancer, obstetrics, blood screening will be less affected.
A general drop of inpatient visits to hospitals and clinics has occurred as a result of lockdown measures.
Large investments in new diagnostic instruments not related to infectious disease testing will slow down as hospitals and labs prepare for the predicted economic downturn.
Renub Research report titled “France In-Vitro Diagnostics (IVD) Market By Segments (Immunochemistry, Hematology, Infectious Immunology, Microbiology, Bio-chemistry, Genetic Testing), Types (Laboratory Reagents, Instruments), Companies (Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Sysmex Corporation)” provides a complete analysis of France In-Vitro Diagnostics (IVD) Industry.
Types - France In-Vitro Diagnostics (IVD) Market have been covered from 2 viewpoints:
1. Laboratory Reagents
2. Instruments
Segments - France In-Vitro Diagnostics (IVD) Market have been covered from 6 viewpoints:
1. Immunochemistry
2. Hematology
3. Infectious Immunology
4. Microbiology
5. Bio-chemistry
6. Genetic Testing
Reimbursement Policy
1. Public
2. Private & Insurance
Companies have been covered from 3 viewpoints
- Overview
- Initiatives & Recent Developments
- Sales
1. Roche Diagnostics
2. Abbott Diagnostics
3. Siemens Healthineers
4. Danaher Corporation
5. Thermo Fisher Scientific
6. Sysmex Corporation
1. INTRODUCTION
2. RESEARCH & METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMIC
4.1 Growth Drivers
4.2 Challenges
5. FRANCE IN-VITRO DIAGNOSTICS (IVD) MARKET
6. MARKET SHARE
6.1 By Types
6.2 By Segments
7. TYPES - FRANCE IN-VITRO DIAGNOSTICS (IVD) MARKET
7.1 Laboratory Reagents
7.2 Instruments
8. SEGMENTS - FRANCE IN-VITRO DIAGNOSTICS (IVD) MARKET
8.1 Immunochemistry
8.2 Hematology
8.3 Infectious Immunology
8.4 Microbiology
8.5 Bio-chemistry
8.6 Genetic Testing
9. GOVERNMENT RULES & REGULATION
10. REIMBURSEMENT
10.1 Public
10.2 Private & Insurance
11. COMPANY ANALYSIS
11.1 Roche Diagnostics
11.1.1 Overviews
11.1.2 Recent Developments
11.1.3 Revenues
11.2 Abbott Diagnostics
11.2.1 Overviews
11.2.2 Recent Developments
11.2.3 Revenues
11.3 Siemens Healthineers
11.3.1 Overviews
11.3.2 Recent Developments
11.3.3 Revenues
11.4 Danaher Corporation
11.4.1 Overviews
11.4.2 Recent Developments
11.4.3 Revenues
11.5 Thermo Fisher Scientific
11.5.1 Overviews
11.5.2 Recent Developments
11.5.3 Revenues
11.6 Sysmex Corporation
11.6.1 Overviews
11.6.2 Recent Developments
11.6.3 Revenues
List Of Figures:
Figure-01: France IVD Market (Million US$), 2015 – 2020
Figure-02: Forecast for – France IVD Market (Million US$), 2021 – 2026
Figure-03: Types – Laboratory Reagents Market (Million US$), 2015 – 2020
Figure-04: Types – Forecast for Laboratory Reagents Market (Million US$), 2021 – 2026
Figure-05: Types – Instruments Market (Million US$), 2015 – 2020
Figure-06: Types – Forecast for Instruments Market (Million US$), 2021 – 2026
Figure-07: Segments – Immunochemistry Market (Million US$), 2015 – 2020
Figure-08: Segments – Forecast for Immunochemistry Market (Million US$), 2021 – 2026
Figure-09: Segments – Hematology Market (Million US$), 2015 – 2020
Figure-10: Segments – Forecast for Hematology Market (Million US$), 2021 – 2026
Figure-11: Segments – Infectious Immunology Market (Million US$), 2015 – 2020
Figure-12: Segments – Forecast for Infectious Immunology Market (Million US$), 2021 – 2026
Figure-13: Segments – Microbiology Market (Million US$), 2015 – 2020
Figure-14: Segments – Forecast for Microbiology Market (Million US$), 2021 – 2026
Figure-15: Segments – Bio-chemistry Market (Million US$), 2015 – 2020
Figure-16: Segments – Forecast for Bio-chemistry Market (Million US$), 2021 – 2026
Figure-17: Segments – Genetic Testings Market (Million US$), 2015 – 2020
Figure-18: Segments – Forecast for Genetic Testings Market (Million US$), 2021 – 2026
Figure-19: Roche Diagnostics – Global Revenue (Million US$), 2015 – 2020
Figure-20: Roche Diagnostics – Forecast for Global Revenue (Million US$), 2021 – 2026
Figure-21: Abbott Diagnostics – Global Revenue (Million US$), 2015 – 2020
Figure-22: Abbott Diagnostics – Forecast for Global Revenue (Million US$), 2021 – 2026
Figure-23: Danaher Corporation – Global Revenue (Million US$), 2015 – 2020
Figure-24: Danaher Corporation – Forecast for Global Revenue (Million US$), 2021 – 2026
Figure-25: Thermo Fisher Scientific – Global Revenue (Million US$), 2015 – 2020
Figure-26: Thermo Fisher Scientific – Forecast for Global Revenue (Million US$), 2021 – 2026
Figure-27: Sysmex Corporation – Global Revenue (Million US$), 2015 – 2020
Figure-28: Sysmex Corporation – Forecast for Global Revenue (Million US$), 2021 – 2026
List Of Tables:
Table-01: France – IVD Market Share by Types (Percent), 2015 – 2020
Table-02: France – Forecast for IVD Market Share by Types (Percent), 2021 – 2026
Table-03: France – IVD Market Share by Segments (Percent), 2015 – 2020
Table-04: France – Forecast for IVD Market Share by Segments (Percent), 2021 – 2026
2. RESEARCH & METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMIC
4.1 Growth Drivers
4.2 Challenges
5. FRANCE IN-VITRO DIAGNOSTICS (IVD) MARKET
6. MARKET SHARE
6.1 By Types
6.2 By Segments
7. TYPES - FRANCE IN-VITRO DIAGNOSTICS (IVD) MARKET
7.1 Laboratory Reagents
7.2 Instruments
8. SEGMENTS - FRANCE IN-VITRO DIAGNOSTICS (IVD) MARKET
8.1 Immunochemistry
8.2 Hematology
8.3 Infectious Immunology
8.4 Microbiology
8.5 Bio-chemistry
8.6 Genetic Testing
9. GOVERNMENT RULES & REGULATION
10. REIMBURSEMENT
10.1 Public
10.2 Private & Insurance
11. COMPANY ANALYSIS
11.1 Roche Diagnostics
11.1.1 Overviews
11.1.2 Recent Developments
11.1.3 Revenues
11.2 Abbott Diagnostics
11.2.1 Overviews
11.2.2 Recent Developments
11.2.3 Revenues
11.3 Siemens Healthineers
11.3.1 Overviews
11.3.2 Recent Developments
11.3.3 Revenues
11.4 Danaher Corporation
11.4.1 Overviews
11.4.2 Recent Developments
11.4.3 Revenues
11.5 Thermo Fisher Scientific
11.5.1 Overviews
11.5.2 Recent Developments
11.5.3 Revenues
11.6 Sysmex Corporation
11.6.1 Overviews
11.6.2 Recent Developments
11.6.3 Revenues
List Of Figures:
Figure-01: France IVD Market (Million US$), 2015 – 2020
Figure-02: Forecast for – France IVD Market (Million US$), 2021 – 2026
Figure-03: Types – Laboratory Reagents Market (Million US$), 2015 – 2020
Figure-04: Types – Forecast for Laboratory Reagents Market (Million US$), 2021 – 2026
Figure-05: Types – Instruments Market (Million US$), 2015 – 2020
Figure-06: Types – Forecast for Instruments Market (Million US$), 2021 – 2026
Figure-07: Segments – Immunochemistry Market (Million US$), 2015 – 2020
Figure-08: Segments – Forecast for Immunochemistry Market (Million US$), 2021 – 2026
Figure-09: Segments – Hematology Market (Million US$), 2015 – 2020
Figure-10: Segments – Forecast for Hematology Market (Million US$), 2021 – 2026
Figure-11: Segments – Infectious Immunology Market (Million US$), 2015 – 2020
Figure-12: Segments – Forecast for Infectious Immunology Market (Million US$), 2021 – 2026
Figure-13: Segments – Microbiology Market (Million US$), 2015 – 2020
Figure-14: Segments – Forecast for Microbiology Market (Million US$), 2021 – 2026
Figure-15: Segments – Bio-chemistry Market (Million US$), 2015 – 2020
Figure-16: Segments – Forecast for Bio-chemistry Market (Million US$), 2021 – 2026
Figure-17: Segments – Genetic Testings Market (Million US$), 2015 – 2020
Figure-18: Segments – Forecast for Genetic Testings Market (Million US$), 2021 – 2026
Figure-19: Roche Diagnostics – Global Revenue (Million US$), 2015 – 2020
Figure-20: Roche Diagnostics – Forecast for Global Revenue (Million US$), 2021 – 2026
Figure-21: Abbott Diagnostics – Global Revenue (Million US$), 2015 – 2020
Figure-22: Abbott Diagnostics – Forecast for Global Revenue (Million US$), 2021 – 2026
Figure-23: Danaher Corporation – Global Revenue (Million US$), 2015 – 2020
Figure-24: Danaher Corporation – Forecast for Global Revenue (Million US$), 2021 – 2026
Figure-25: Thermo Fisher Scientific – Global Revenue (Million US$), 2015 – 2020
Figure-26: Thermo Fisher Scientific – Forecast for Global Revenue (Million US$), 2021 – 2026
Figure-27: Sysmex Corporation – Global Revenue (Million US$), 2015 – 2020
Figure-28: Sysmex Corporation – Forecast for Global Revenue (Million US$), 2021 – 2026
List Of Tables:
Table-01: France – IVD Market Share by Types (Percent), 2015 – 2020
Table-02: France – Forecast for IVD Market Share by Types (Percent), 2021 – 2026
Table-03: France – IVD Market Share by Segments (Percent), 2015 – 2020
Table-04: France – Forecast for IVD Market Share by Segments (Percent), 2021 – 2026
